Hasil Pencarian - Ruth Pettengell

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Relaxation and exercise in lymphoma survivors (REIL study): a randomised clinical trial protocol

    Relaxation and exercise in lymphoma survivors (REIL study): a randomised clinical trial protocol oleh Suchita Hathiramani, Ruth Pettengell, Hannah Moir, Ahmed Younis

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy

    Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy oleh Timothy H. Scott‐Taylor, Stefan‐Claudiu Axinia, Sumeya Amin, Ruth Pettengell

    Diterbitkan 2018-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Construction of the secondary care administrative records frailty (SCARF) index and validation on older women with operable invasive breast cancer in England and Wales: a cohort study

    Construction of the secondary care administrative records frailty (SCARF) index and validation on older women with operable invasive breast cancer in England and Wales: a cohort st... oleh David A Cromwell, Thompson Robinson, Yasmin Jauhari, Melissa Ruth Gannon, Kieran Horgan, Karen Clements, Jibby Medina, Carmen Tsang, Sarah Shuk-Kay Tang, Ruth Pettengell

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

    Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma oleh Tim M. Illidge, Elizabeth H. Phillips, Nicholas Counsell, Ruth Pettengell, Peter W.M. Johnson, Dominic J. Culligan, Bilyana Popova, Laura Clifton-Hadley, Andrew McMillan, Peter Hoskin, Sally F. Barrington, John Radford

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial

    Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial oleh Elizabeth H. Phillips, Catherine Burton, Amy A. Kirkwood, Sharon Barrans, Anthony Lawrie, Simon Rule, Russell Patmore, Ruth Pettengell, Kirit M. Ardeshna, Silvia Montoto, Shankara Paneesha, Laura Clifton‐Hadley, David C. Linch, Andrew K. McMillan

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: